Literature DB >> 23337859

Setting high-impact clinical research priorities for the Society for Vascular Surgery.

Larry W Kraiss1, Michael S Conte, Randolph L Geary, Melina Kibbe, C Keith Ozaki.   

Abstract

With the overall goal of enhancing the effectiveness and efficiency of vascular care, the Society for Vascular Surgery (SVS) recently completed a process by which it identified its top clinical research priorities to address critical gaps in knowledge guiding practitioners in prevention and treatment of vascular disease. After a survey of the SVS membership, a panel of SVS committee members and opinion leaders considered 53 distinct research questions through a structured process that resulted in identification of nine clinical issues that were felt to merit immediate attention by vascular investigators and external funding agencies. These are, in order of priority: (1) define optimal management of asymptomatic carotid stenosis, (2) compare the effectiveness of medical vs invasive treatment (open or endovascular) of vasculogenic claudication, (3) compare effectiveness of open vs endovascular infrainguinal revascularization as initial treatment of critical limb ischemia, (4) develop and compare the effectiveness of clinical strategies to reduce cardiovascular and other perioperative complications (eg, wound) after vascular intervention, (5) compare the effectiveness of strategies to enhance arteriovenous fistula maturation and durability, (6) develop best practices for management of chronic venous ulcer, (7) define optimal adjunctive medical therapy to enhance the success of lower extremity revascularization, (8) identify and evaluate medical therapy to prevent abdominal aortic aneurysm growth, and (9) evaluate ultrasound vs computed tomographic angiography surveillance after endovascular aneurysm repair.
Copyright © 2013 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23337859     DOI: 10.1016/j.jvs.2012.09.069

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  7 in total

1.  Metformin prescription status and abdominal aortic aneurysm disease progression in the U.S. veteran population.

Authors:  Nathan K Itoga; Kara A Rothenberg; Paola Suarez; Thuy-Vy Ho; Matthew W Mell; Baohui Xu; Catherine M Curtin; Ronald L Dalman
Journal:  J Vasc Surg       Date:  2018-09-06       Impact factor: 4.268

2.  Expanding our understanding of patient outcomes: the unique role of health services research in the continuing evolution of surgical science.

Authors:  Taylor M Coe; John A Rose; David C Chang
Journal:  Vasc Endovascular Surg       Date:  2014-01-19       Impact factor: 1.089

3.  Regional variation in patient outcomes in carotid artery disease treatment in the Vascular Quality Initiative.

Authors:  Katie E Shean; Thomas F X O'Donnell; Sarah E Deery; Alexander B Pothof; Joseph R Schneider; Caron B Rockman; Brian W Nolan; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2018-03-20       Impact factor: 4.268

4.  Regional variation in patient selection and treatment for carotid artery disease in the Vascular Quality Initiative.

Authors:  Katie E Shean; John C McCallum; Peter A Soden; Sarah E Deery; Joseph R Schneider; Brian W Nolan; Caron B Rockman; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2017-03-27       Impact factor: 4.268

Review 5.  Carotid revascularization: risks and benefits.

Authors:  Marlene O'Brien; Ankur Chandra
Journal:  Vasc Health Risk Manag       Date:  2014-07-07

6.  Remote effects of lower limb ischemia-reperfusion: impaired lung, unchanged liver, and stimulated kidney oxidative capacities.

Authors:  Z Mansour; A L Charles; M Kindo; J Pottecher; T N Chamaraux-Tran; A Lejay; J Zoll; J P Mazzucotelli; B Geny
Journal:  Biomed Res Int       Date:  2014-08-10       Impact factor: 3.411

7.  Recombinant Interleukin-19 Suppresses the Formation and Progression of Experimental Abdominal Aortic Aneurysms.

Authors:  Hiroki Tanaka; Baohui Xu; Haojun Xuan; Yingbin Ge; Yan Wang; Yankui Li; Wei Wang; Jia Guo; Sihai Zhao; Keith J Glover; Xiaoya Zheng; Shuai Liu; Kazunori Inuzuka; Naoki Fujimura; Yuko Furusho; Toru Ikezoe; Takahiro Shoji; Lixin Wang; Weiguo Fu; Jianhua Huang; Naoki Unno; Ronald L Dalman
Journal:  J Am Heart Assoc       Date:  2021-08-28       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.